NCPIC - National Cannabis Prevention and Information Centre

Publications Bulletin - December 2009

Relevant publications examining issues to do with cannabis that have been published in the last month include the following:

  • Chédebois, L., Régner, I., van Leeuwen, N., Chauchard, E., Séjourné, N., Rodgers, R., & Chabrol, H. (2009). Relative contributions of acculturation and psychopathological factors to cannabis use among adolescents from migrant parents. Addictive Behaviors 34, 1023-1028.
  • Comelli, F., Bettoni, I., Colleoni, M., Giagnoni, G., & Costa, B. (2009). Beneficial effects of a cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress. Phytotherapy Research 23, 1678-1684.
  • De Backer, B., Debrus, B., Lebrun, P., Theunis, L., Dubois, N., Decock, L., Verstraete, A., Hubert, P., & Charlier, C. (2009). Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material. Journal of Chromatography - Analytical Technologies in the Biomedical and Life Sciences 877, 4115-4124.
  • Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T.R., Handley, R., Luzi, S., Russo, M., Paparelli, A., Butt, A., Stilo, S.A., Wiffen, B., Powell, J., & Murray, R.M. (2009). High-potency cannabis and the risk of psychosis. British Journal of Psychiatry 195, 488-491.
  • Guindon, J. & Hohmann, A.G. (2009). The endocannabinoid system and pain. CNS and Neurological Disorders - Drug Targets 8, 403-421.
  • Karschner, E.L., Schwilke, E.W., Lowe, R.H., Darwin, W.D., Pope, H.G., Herning, R., Cadet, J.L., & Huestis, M.A. (2009). Do delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? Addiction 104, 2041-2048.
  • Lakhan, S.E. & Rowland, M. (2009). Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review. BMC Neurology 9, 59.
  • Mariani, J.J., Haney, M., Hart, C.L., Vosburg, S.K., & Levin, F.R. (2009). Effects of research setting on observed depressive symptoms in marijuana users. Journal of Substance Abuse Treatment 37, 431-434.
  • Price, C., Hemmingsson, T., Lewis, G., Zammit, S., & Allebeck, P. (2009). Cannabis and suicide: Longitudinal study. British Journal of Psychiatry 195, 492-497.
  • Reiman, A. (2009). Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal 6, 35.
  • Schwilke, E.W., Schwope, D.M., Karschner, E.L., Lowe, R.H., Darwin, W.D., Kelly, D.L., Goodwin, R.S., Gorelick, D.A., & Huestis, M.A. (2009). Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC. Clinical Chemistry 55, 2180-2189.
  • Sheer, A.J., Gorelick, D.A., Collins, C.C., Schroeder, J.R., Heishman, S.J., Leff, M.K., & Moolchan, E.T. (2009). Interest in marijuana treatment programs among teenage smokers and nonsmokers. Journal of Substance Abuse Treatment 37, 421-425.
  • Stanger, C., Budney, A.J., Kamon, J.L., & Thostensen, J. (2009). A randomized trial of contingency management for adolescent marijuana abuse and dependence. Drug and Alcohol Dependence 105, 240-247.